Interactions among antibiotics, bacteria and the human immune system: The clinical relevance of in vitro testing

Journal of Chemotherapy

Volumn 9, Issue SUPPL. 1, 1997, Pages 109-115

  Bergogne Berezin, E ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Antibiotic activity; Immune system; Immunomodulation; In vitro antibiotic testing

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL ANTIGEN; BACTERIAL ENZYME; CARBENICILLIN; CEFADROXIL; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFODIZIME; CEFOXITIN; CEFRADINE; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; CYTOKINE; ERYTHROMYCIN; MACROLIDE; RIFAMPICIN; ROXITHROMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; IMMUNE SYSTEM; MICROBIAL SENSITIVITY TESTS;

EID: 0030849693     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Washington JA. Diagnosis of infectious diseases. Clinical microbiology. In: Gorbach SL, Bartlett JG, Blacklow NR (Ed) Infectious diseases, Saunders WB, (Harcourt Brace Jovanovich, Inc). 1992: 107-126.
2. Courvalin P, Goldstein F, Philippon A, Sirot J. L'antibiogramme. Fiches techniques 5,6,7,8. MPC-Videom publisher. Paris, 1985: 189-218.
3. Brown MRW, Williams P. Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents. J Antimicrob Chemother 1985; 15 (Suppl. A): 7-14.
4. Dalhoff A. Differences between bacteria grown in vitro and in vivo. J Antimicrob Chemother 1985; 15 (Suppl A): 175-195.
5. Darveau RP, Cunningham MD. Influence ot subinhibitory concentration of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa. J Infect Dis 1990; 162: 914-921.
6. Drusano GL. Role of pharmacokinetics in outcome of infection. Antimicrob Agents Chemother 1988; 32: 289-297.
7. MacGowan A. Concentration controlled and concentration defined clinical trials: do they offer any advantages for antimicrobial chemotherapy? J Antimicrob Chemother 1996; 37: 1-6.
8. Ritts RE. Antibiotics as biological response modifiers. J Antimicrob Chemothcr 1990; 26: 31-36.
9. Barza M. Principles ot tissue penetration ot antibiotics. J Antimicrob Chemother 1981; 8 (Suppl. C): 7-28.
10. Nix DE, Goodwin SD, Peloquin CA, Rotella DL, Schentag JJ. Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning. Antimicrob Agents Chemother 1991; 35: 1947-1952.
11. Barza M. Challenges to antibiotic activity in tissue. Clin Infect Dis 1994; 19: 910-915.
12. Salyers AA, Whin DD. Bacterial pathogenesis. Chapter 2: Host defenses against bacterial pathogens defenses of tissue and blood. A S M Press, Washington DC, 1994: 16-28.
13. Gemmel CG. Changes in expression ot bacterial surface antigens induced by antibiotics and their influence on host defences. Pathol Biol 1987; 35: 1377-81.
14. Shibl AM. Influence ot subinhibitory concentrations of antibiotics on virulence of staphylococci. Rev Infect Dis 1987; 9: 704-12.
15. Svanborg-Eden EC, Sandberg T, Ahlestedt K. Decrease in adhesion of Escherichia coli to human urinary tract epithelial cells in vitro by subinhibitory concentration ot ampicillin. Intection 1978; 6: 121-24.
16. Vanden Brock PJ. Antimicrobial drugs microorganisms and phagocytes. Rev Infect Dis 1989; 11: 212-45.
17. McDonald PJ, Wetherall BL, Pruul H. Post antibiotic leucocyte enhancement : increased susceptibility of bacteria pretreated with antibiotics to activity ol leucocytes. Rev Infect Dis 1991; 3: 38-44.
18. Veringa EM, Verhoef J. Clindamycin at subinhibitory concentrations enhances antibody and emplement dependent phagocytosis by human polymorphonuclear leucocytes of Staphylococcus aureus. Chemotherapy 1987; 33: 243-249.
19. Raponi G, Keller N, Rozenberg-Arska M, Hoepelman IM, Verhoef J. The influence ot cefepime on opsonophagoctosis of bacteria. Drugs Exptl Clin Res 1989;15: 141-144.
20. Gemmel CG. Expression ot virulence factors of bacteria when grown in the presence ol subminimum inhibitory concentrations of various antibiotics. Drugs Exptl Clin Res 1982; 8: 245-50.
21. Pruul H, McDonald PJ. Damage to bacteria by antibiotics in vitro and its relevance to antimicrobial chemotherapy, a historical perspective. J Antimicrob Chemother 1988; 21: 695-698.
22. Lagrange PH, Richet H, Escande MC. In vitro effects of SubMICs of antibiotics on the antigenicity of Pseudomonas aeruginosa. In: Szentivanyi A, Friedman H, Gillissen G (Eds), Antibiotics and Host Immunity. New-York, Plenum Press, 1987: 51-62.
23. Ravoni G, Keller N, Overbeek BP. Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria. J Infect Dis 1991; 163: 122-127.
24. Cohen J, Mc Connell JS. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. Eur J Clin Microbiol 1986; 5: 13-17.
25. Dajani BM, Kasik JE, Thompson JS. Effect of rifampicin on the immune response in guinea-pigs. Antimicrob Agents Chemother 1973; 3: 451-455.
26. Clot J. Antibody isotypic regulation and antibiotics. Pathol Biol 1993; 4: 1-7.